Clinical Trial Update: CAR-NK Cells (CL-NK-001) in Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial (CL-NK-001) evaluating CAR-NK cell therapy for pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CL-NK-001

Snippet

Sponsor: Changhai Hospital | Conditions: Pancreatic Cancer | Phase 1 | Status: RECRUITING